Cárdenas CR

Language: Spanish
References: 7
Page: 68-72
PDF size: 70.60 Kb.

ABSTRACT

Currently the bone marrow transplant (BMT) represents an alternative in the treatment of hemathologic and malignant neoplasias, it’s accepted like a standard regimen of treatment for cancer and other diseases (aplastic anemia, immunodeficiencies, etc. There are differents style of BMT: autologous, allogeneic (HLA donor) and stem cell transplant. Recently studies show the results with this treatment are encouraging, this is one of the reasons for many cancer centers develope this kind of program.

REFERENCES

1. Beard ME. Bone marrow transplantation: Technique and current indications. N Med J 1980; 91: 103.

2. Champling RE, Gale RP. Role of marrow transplantation in the treatment of hematologic malignancies and solid tumors. Critical review of syngeneic autologous and allogeneic transplants. Cancer Treat Rep 1984; 68: 145-161.

3. Hows JM, Yin JL, Marhs J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.

4. Santo GW, Tutscka P, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983; 309: 1347.

5. Thomas ED, Storb R, Cliff RA et al. Bone marrow transplantation. N Engl Med 1975; 292: 895-901.

6. Herzig RH, Barret AJ, Gluckman G et al. Bone marrow transplantation in high-risk acute lymphoblastic leukemia in first and second remission. Lancet 1987: 786-790.

7. Muñoz VA. Trasplante de médula ósea en: Oncología pediátrica: Sierrasesúmaga L, Calvo F, I Villa-Elízaga (EDS) McGraw-Hill España 1992: 232-248.